Summary Familial predisposition to basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) of the skin are apparent in the autosomal dominant syndromes naevoid basal cell carcinoma syndrome (NBCCS) and multiple self-healing squamous epitheliomata (MSSE) respectively. The gene responsible for NBCCS has been proposed to be a tumour-suppressor gene and is mapped to the same 2 Mb interval on 9q22.3 as the MSSE gene ESSI. In an attempt to further map the NBCCS gene, we have examined loss of heterozygosity (LOH) in 16 sporadic BCCs and two familial BCCs using microsatellite markers located within the candidate gene region. The overall frequency of LOH observed was 67% in the BCCs and partial or interstitial deletions were found in eight tumours, with the highest LOH frequency at markers D9S280, D9S287 and D9S180. To determine if the same genomic region also shows frequent LOH in tumours with a squamous phenotype, we have examined 11 SCCs, four actinic keratoses and 13 cases of Bowen's disease for LOH at 9q22.3. An overall LOH frequency of 50% was observed at D9S180, and occurred in all types of squamous tumours. In contrast, a much lower LOH frequency of only 6% was found at the D9S287 locus. Our observation of different patterns of LOH at 9q22.3 in sporadic BCCs and SCCs implies that more than one tumour-suppressor gene might be located in this genomic region.
Skin cancer is the most common cancer in the Western world (Ko et al., 1994) . A major part of these are non-melanoma skin cancers with basal cell carcinomas (BCCs) accounting for more than 75% and squamous cell carcinomas (SCCs) for 20% (Miller, 1991; Kwa et al., 1992) . Both BCCs and SCCs are derived from the same cell type, the keratinocyte, and show clear biological and clinical differences. BCCs grow slowly and are mainly locally aggressive, but rarely metastasise, whereas SCCs grow faster and do metastasise (Weedon, 1992) . Basal cell carcinoma occurs predominantly as sporadic cases but also as familial cases in an autosomal dominant disease called the naevoid basal cell carcinoma syndrome (NBCCS) (McKusick number 109400), having an estimated minimum incidence of 1 in 55 600 (Evans et al., 1993) . NBCCS predisposes to multiple BCCs, and some other types of tumours such as ovarian fibromas, medulloblastomas and cardiac fibromas. The disease is also associated with widespread developmental defects (Gorlin, 1987) . Squamous cell carcinoma on the other hand occurs almost exclusively as sporadic cases, although in a rare autosomal dominant disease called multiple self-healing squamous epitheliomata (MSSE) (McKusick number 132800) tumours morphologically similar to well-differentiated SCCs are seen (Goudie et al., 1993) . Through linkage analysis of kindreds with NBCCS the gene for this syndrome has been mapped to the 9q22-31 region (Farndon et al., 1992; Gailani et al., 1992; Reis et al., 1992; Chenevix-Trench et al., 1993) . Further mapping has limited the candidate genomic region to a 2 Mb interval on 9q22.3 between microsatellite markers D9S196 and D9S180 (Goldstein et al., 1994; Wicking et al., 1994) , whereas the interval between markers D9S12/D9S151 and D9S287 was implicated in another study . With regard to the disorder MSSE the corresponding gene, ESSI, has also been mapped to chromosome 9q22-31 (Goudie et al., 1993) , with a likely location in the interval between D9S196 and D9S180 (Povey et al., 1994) .
The NBCCS gene has been proposed to be a tumoursuppressor gene based on the finding of frequent loss of heterozygosity (LOH) in the NBCCS genomic region, 9q22-31, in both sporadic and familiar BCCs, and in other tumour types seen in the syndrome such as medulloblastomas (Gailani et al., 1992; Quinn et al., 1994a; Schofield et al., 1995) . Further evidence that supports the tumour-suppressor gene theory is that the allele deleted in BCCs from NBCCS patients was found to be the non-disease-transmitting allele (Bonifas et al., 1994) . As the NBCCS and the ESSI genes map to the same genomic region it has been speculated that either two different genes reside in this area or that different mutations in the same gene may explain the different clinical features of the two disorders. Although there have not been any studies of LOH on chromosome 9q in tumours from MSSE patients, loss of chromosome 9q alleles have been reported in sporadic skin SCCs (Quinn et al., 1994b; Zaphiropoulos et al., 1994) .
In order to confirm the frequent loss of the 9q22. (Shanley et al.. 1995) . However, in their study the putative location was based on information derived from only two sporadic BCCs. One possible way to reconcile the pattern of LOH observed in our study and published critical recombinants placing the gene between D9S196 and D9S287 : Wicking et al.. 1994 ) is if the D9S287 marker is intragenic to the NBCCS gene. The only genes presently known to be located in the interval between D9S196 and D9S180 is Fancom' anaemia group C (FACC) and xeroderma pigmentosum complementation group A (XPAC). which both have been excluded as the NBCCS gene based on mutational analysis (Bare et al., 1995) .
In SCCs of the skin and premalignant lesions such as actinic keratoses and Bowen's disease a strikingly different pattern of LOH was observed with a high frequency of LOH (50%) observed at D9S180 but essentially no loss (6%) at D9S287. Whether a new putative tumour-suppressor gene of importance for development of SCCs resides at or distal to D9S180. with the marker D9S287 as the proximal border of the deleted region, remains to be investigated by further deletion mapping using markers distal to D9S1 80. One previous study reported only a low frequency of LOH at 9q22.3 in SCCs in spite of more overall widespread genetic changes compared with BCCs (Quinn et al.. 1994c) . However. in a subsequent study from the same group a LOH frequency of 44% in this genomic region in actinic keratoses was observed (Rehman et al.. 1994) . It is also highly interesting to note that frequent LOH in the 9q22-34 area has been reported in squamous cell carcinomas from other tissues such as oesophagus, head and neck and bladder (Ah-See et al.. 1994 : Mon' et al., 1994 Habuchi et al.. 1995; Miura et al.. 1995) . Furthermore. consistent with our observation of LOH at D9SI80 already in premalignant lesions, these studies also support the notion that loss of genetic material on 9q is an early event in development of squamous cell cancer. whereas loss on 9p in the region harbouring the CDKN2 gene (also called MUTSJ) appears later.
We did not detect RERs in the tumours analysed. which is consistent with earlier reports finding microsatellite length alterations at more than one loci to be rare in non-melanoma skin cancer (Zaphiropoulos et al.. 1994 
